KMS Medisurgi (BOM:540468) Marketable Securities: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540468 KMS Medisurgi Ltd BOM:540468
79 GF Score
Price ₹132.80
GF Value ₹111.50
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is KMS Medisurgi Marketable Securities?

KMS Medisurgi BOM:540468 79 Marketable Securities is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. KMS Medisurgi's Marketable Securities for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

KMS Medisurgi  (BOM:540468) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

KMS Medisurgi Marketable Securities Related Terms

KMS Medisurgi Marketable Securities Historical Data

* Premium members only.

The historical data trend for KMS Medisurgi's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KMS Medisurgi Marketable Securities Chart

KMS Medisurgi Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

KMS Medisurgi Semi-Annual Data
Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:540468
79GF Score
KMS Medisurgi Ltd BOM:540468
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KMS Medisurgi Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0.0 Mil mean?
KMS Medisurgi (BOM:540468) has a Marketable Securities of ₹0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on KMS Medisurgi and its competitors.
Is KMS Medisurgi's Marketable Securities too high?
KMS Medisurgi's current Marketable Securities is ₹0.0 Mil. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's Marketable Securities compare to ISRG and BDX?
KMS Medisurgi's Marketable Securities of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on KMS Medisurgi and its competitors. KMS Medisurgi's current Marketable Securities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current Marketable Securities is ₹0.0 Mil. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current Marketable Securities is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KMS Medisurgi (BOM:540468) Overvalued in 2026?

Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued. The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50. GuruFocus considers KMS Medisurgi to be Modestly Overvalued.

Key valuation signals for BOM:540468:

  • Marketable Securities: ₹0.0 Mil
  • GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KMS Medisurgi Business Description

Address Princess Street, Ground Floor, 297-301, May Building, Marine Lines (East, Mumbai, MH, IND, 400002
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score

Get the complete analysis for BOM:540468

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹132.80
Price
₹111.50
GF Value